The growing interest in
cancer epigenetics is largely due to the reversible nature of epigenetic changes which tend to alter during the course of
carcinogenesis. Major epigenetic changes including DNA methylation,
chromatin modifications and
miRNA regulation play important roles in tumorigenic process. There are several epigenetically active synthetic molecules such as
DNA methyltransferase (DNMTs) and
histone deacetylases (HDACs) inhibitors, which are either approved or, are under clinical trials for the treatment of various
cancers. However, most of the synthetic inhibitors have shown adverse side effects, narrow in their specificity and also expensive. Hence, bioactive
phytochemicals, which are widely available with lesser toxic effects, have been tested for their role in epigenetic modulatory activities in gene regulation for
cancer prevention and
therapy. Encouragingly, many bioactive
phytochemicals potentially altered the expression of key tumor suppressor genes,
tumor promoter genes and oncogenes through modulation of DNA methylation and
chromatin modification in
cancer. These bioactive
phytochemicals either alone or in combination with other
phytochemicals showed promising results against various
cancers. Here, we summarize and discuss the role of some commonly investigated
phytochemicals and their epigenetic targets that are of particular interest in
cancer prevention and
cancer therapy.